Neuronoff implants injectable electrode in first-in-human study

Neuronoff has completed the first implants of its Injectrode device in a first-in-human study evaluating its use in chronic pain management.

The minimally invasive injectable electrode works by a type of neuromodulation called transcutaneous electrical nerve stimulation (TENS).

US-based Neuronoff says that unlike traditional techniques using the technology that uses wires or bulges on the outside, its injected lead preserves patient privacy and gives an “aesthetic result”. An external pulse generator sends signals through the skin to tell the implanted electrode what electrical output is needed on the nerve.

Other types of chronic neuromodulation treatment involve implanting...